GeneDx Holdings Corp. Quarterly Operating Margin in % from Q4 2020 to Q4 2024

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
GeneDx Holdings Corp. quarterly/annual Operating Margin history and growth rate from Q4 2020 to Q4 2024.
  • GeneDx Holdings Corp. Operating Margin for the quarter ending December 31, 2024 was -7.6 %, a 91.5% increase year-over-year.
  • GeneDx Holdings Corp. annual Operating Margin for 2024 was -7.6 %, a 91.5% increase from 2023.
  • GeneDx Holdings Corp. annual Operating Margin for 2023 was -89.2 %, a 68.7% increase from 2022.
  • GeneDx Holdings Corp. annual Operating Margin for 2022 was -284 %, a 35.3% decline from 2021.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q4 2024 -7.6 +81.6 +91.5% Oct 1, 2024 Dec 31, 2024
Q3 2024 -21.6 +211 +90.7% Jul 1, 2024 Sep 30, 2024
Q2 2024 -38.1 +185 +82.9% Apr 1, 2024 Jun 30, 2024
Q1 2024 -60.4 +225 +78.8% Jan 1, 2024 Mar 31, 2024
Q4 2023 -89.2 +195 +68.7% Oct 1, 2023 Dec 31, 2023
Q3 2023 -232 -34 -17.1% Jul 1, 2023 Sep 30, 2023
Q2 2023 -223 +15.4 +6.47% Apr 1, 2023 Jun 30, 2023
Q1 2023 -285 -118 -70% Jan 1, 2023 Mar 31, 2023
Q4 2022 -284 -74.2 -35.3% Oct 1, 2022 Dec 31, 2022
Q3 2022 -198 +10.2 +4.89% Jul 1, 2022 Sep 30, 2022
Q2 2022 -239 -40.7 -20.6% Apr 1, 2022 Jun 30, 2022
Q1 2022 -168 +41.4 +19.8% Jan 1, 2022 Mar 31, 2022
Q4 2021 -210 -75.3 -55.8% Oct 1, 2021 Dec 31, 2021
Q3 2021 -209 Jul 1, 2021 Sep 30, 2021
Q2 2021 -198 Apr 1, 2021 Jun 30, 2021
Q1 2021 -209 Jan 1, 2021 Mar 31, 2021
Q4 2020 -135 Oct 1, 2020 Dec 31, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.